Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Evidence And Privacy topic
No spam. Unsubscribe anytime.
Department places medical records under seal and takes official notice of opioid effects
Summary
The Department entered investigative and medical exhibits under seal because they contain protected medical information and, pursuant to statute, the hearing officer took official notice of the pharmacological effects of oxycodone, oxymorphone and fentanyl; neither party offered contradictory evidence.
Get email alerts on the Evidence And Privacy topic
No spam. Unsubscribe anytime.
The Department of Public Health identified an investigative report (dated 07/25/2025) and partial medical records and laboratory results (May–July 2025) as Department exhibits and Hearing Officer Aiden Baum announced those exhibits would be entered under seal because they contain protected medical information. "I'm gonna... enter this under seal because it contains protected medical information," he stated when admitting the documents to the record.
Separately, the hearing officer said he would take official notice, pursuant to Connecticut General Statutes 4-178 subsection 6, of the generally recognized pharmacological effects of certain opioid agonists. He listed oxycodone, oxymorphone and fentanyl and identified their commonly recognized effects as "sedation, respiratory depression, and impaired cognitive and ... psychomotor function." Neither the Department nor the respondent offered evidence to dispute that official notice at the time it was taken.

